Related Experiment Videos
Resveratrol arrests the cell division cycle at S/G2 phase transition
F D Ragione1, V Cucciolla, A Borriello
1Medical School, Second University of Naples, Naples, Italy. dellarag@cds.unina.it
Biochemical and Biophysical Research Communications
|September 15, 1998
Summary
Resveratrol, a compound found in grapes, halts HL-60 cell proliferation and triggers differentiation. It causes a reversible cell cycle arrest at the S phase checkpoint, impacting cell division regulators.
Area of Science:
- * Pharmacology
- * Cell Biology
- * Biochemistry
Background:
- * Resveratrol (3,5,4'-trihydroxystilbene) is a natural phytoalexin found in grapes and wine.
- * It exhibits diverse pharmacological effects.
- * Its impact on cell proliferation and differentiation requires further investigation.
Purpose of the Study:
- * To investigate the effects of resveratrol on HL-60 cell proliferation and differentiation.
- * To elucidate the cell cycle mechanisms underlying resveratrol's activity.
Main Methods:
- * Treatment of HL-60 cells with varying concentrations of resveratrol.
- * Cell proliferation assessed via cell counting.
- * Differentiation evaluated by observing phenotypic changes.
- * Cell cycle analysis using flow cytometry.
- * Biochemical analysis of cell cycle regulatory proteins (cyclins, cdc2).
Main Results:
- * Resveratrol (≥30 μM) completely arrested HL-60 cell proliferation.
- * Induced differentiation towards a myelo-monocytic phenotype.
- * Caused cell accumulation in G1 and S phases, with no G2/M peak.
- * Showed minimal apoptosis at effective concentrations.
- * Resveratrol induced S phase arrest by increasing cyclins A and E and accumulating inactive phosphorylated cdc2, without affecting the G1 phase.
Conclusions:
- * Resveratrol effectively inhibits HL-60 cell proliferation and promotes differentiation.
- * It induces a reversible cell cycle arrest specifically at the S phase checkpoint.
- * The mechanism involves modulation of key cell cycle regulators, offering potential therapeutic insights.